Dermapharm SE Laborant bei der Arbeit mit Geräten

The Company

Company Profile

Dermapharm - Pharmaceutical Excellence
“Made in Europe”

Dermapharm is an innovative and rapidly growing manufacturer of branded pharmaceuticals and other healthcare products. Founded in 1991, the Company is based in Grünwald near Munich. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Germany, the rest of Europe and the United States.

In the "Branded pharmaceuticals" segment, Dermapharm has more than 1,300 marketing authorisations with more than 400 active pharmaceutical ingredients. Dermapharm's portfolio of pharmaceuticals is tailored to selected therapeutic areas in which the Company is a market leader, especially in Germany. The Company's integrated business model extends from in-house product development and production through quality management and logistics to the distribution of branded pharmaceuticals by a trained pharmaceutical sales force.

Dermapharm bundles food supplements, herbal pharmaceuticals, cosmetics, medical devices, herbal extracts and medicinal cannabis in its "Other healthcare products" segment. In this segment, Dermapharm can tap the expertise of the Spanish company Euromed S.A., a leading global manufacturer of herbal extracts and plant-based active ingredients for the pharmaceuticals, nutraceuticals, foodstuffs and cosmetics industries, and Arkopharma, the market leader for herbal medicines and food supplements in France.

Dermapharm also operates the "Parallel import business" segment under the axicorp brand. axicorp imports originator pharmaceuticals from other EU Member States and resells them to pharmaceuticals wholesalers and pharmacies in Germany. This enables axicorp to benefit from the different pricing structures in the individual EU member states. Based on revenue, axicorp is currently one of the top six parallel import companies in Germany.

With a consistent R&D strategy and numerous successful product and company acquisitions and by stepping up its internationalisation efforts, the Group is continuously optimising its business activities and seeks external growth opportunities in addition to organic growth.


Management Board

Members of the Management Board of Dermapharm Holding SE



Dr Hans-Georg Feldmeier holds the position of CEO at Dermapharm. He joined the company in 2003 as the manager responsible for setting up production in Sandersdorf-Brehna. He has been Dermapharm's Chief Production & Development Officer since 2009. Dr Feldmeier began his professional career in 1987 at Berlin-Chemie AG. As Head of Production and Technology, he was instrumental in modernising the company after the fall of the Berlin Wall. In 2002, he was Head of the Supply Centre at Schering Aktiengesellschaft, Berlin

Photo: ©BPI Kruppa

Dermapharm SE Foto von Dr. Hans-Georg Feldmeier



Dr. Andreas Eberhorn has been responsible for marketing and sales at Dermapharm as Chief Marketing Officer since 1 September 2022. He holds a doctorate in biology and has many years of experience in the pharmaceutical industry. From 2014 to 2018, he was already responsible for the specialty business as a member of the Management Board of Hexal AG. Since 2018, he has been Country Head at Sandoz Austria and most recently Head of Retail Cluster II (Rx and OTC) for the European region at Sandoz.



Christof Dreibholz has been responsible for Finance, Controlling, Accounting and Taxes as Chief Financial Officer since 1 November 2022. As Chief Compliance Officer, he is also responsible for Governance, Risk & Compliance. Christof Dreibholz is a qualified auditor and tax advisor and has been with Deloitte since 2002. As a partner, he has been responsible for the implementation of financial due diligence projects since 2008. Mr Dreibholz has advised the Dermapharm Group on numerous national and international acquisitions and has been familiar with the structures of the Dermapharm Group for many years.

Supervisory Board

Members of the Supervisory Board of Dermapharm Holding SE



Wilhelm Beier was born in Eicherscheid (Bad Münstereifel), Germany, on April 21, 1956. Starting his career in 1981, he held various positions in the pharmaceuticals industry, including a managing director of the German subsidiaries of an international pharmaceuticals manufacturer. After founding Dermapharm in 1991, Mr. Beier served as Chief Executive Officer of Dermapharm AG.

In 2017, he was appointed chairman of the supervisory board of Dermapharm.

Mr. Beier and his family hold the majority of the company's shares via Themis Beteiligungs AG.


Dr Erwin Kern was born on July 6, 1960 in Karlsruhe, Germany. In 1986, Dr. Kern completed his studies in business administration at the Ludwig Maximilian University in Munich. In 1989, he received his doctorate in economics from the University of Paderborn. Dr. Kern began his professional career in 1986 as Managing Director of HBK-Handel und Beteiligungen Kern GmbH & Co. KG. From 1991 onwards, he was a member of the management of Kies und Beton Baden-Baden GmbH & Co. Holding KG and Kies und Beton AG Baden-Baden. In 2007, Dr. Kern took over the chairmanship of the management of these companies, which he still holds today. Since 2003, he has been President of the Federal Association of the German Ready-Mixed Concrete Industry (BTB). (BTB) since 2003 and was Chairman from 2008 to 2011 and Vice Chairman from 2011 to 2013 of Construction Products Europe (CPE) (Association of European Construction Materials Manufacturers).

Dr Kern was appointed as a member of the Supervisory Board of Dermapharm Holding SE in 2017. In addition to his position at Dermapharm, Dr Kern was and is active in various companies and associations in the stone and earth industry that are not listed on the stock exchange.


Lothar Lanz was born on October 1, 1948 in Bihlafingen, Germany. From 1969 to 1974, Mr. Lanz studied business administration at the universities of Stuttgart and Berlin and graduated with a degree in business administration. Mr. Lanz began his professional career as an audit assistant for an auditor and tax consultant in Berlin. In 1977, Mr. Lanz joined Bayerische Hypotheken- und Wechselbank AG, where he served as branch manager from 1983 to 1990. In 1991, Mr. Lanz became a member of the Board of Management of H.S.B. HYPO Service-Bank AG, Munich. In 1996, he moved to Nassauische Sparkasse, Wiesbaden, where he also became a member of the Board of Management. In the same year, Mr. Lanz moved to the then ProSieben Media AG (now ProSiebenSat.1 Media AG) as Chief Financial Officer, a post he held until 2008. From 2009 to 2014, Mr. Lanz was a member of the Executive Board of Axel Springer AG (now Axel Springer SE), where he served as Chief Financial and Operating Officer.

Mr. Lanz was appointed as a member of the Supervisory Board of Dermapharm Holding SE in 2018. In addition, he is currently Chairman of the Supervisory Board of Home 24 SE, a member of the Supervisory Board of TAG Immobilien AG and the unlisted Bauwert AG as well as Chairman of the Board of Directors of the unlisted SMG Swiss Marketplace Group AG. Until 2019, he was also a member of the Supervisory Board of Axel Springer SE and Chairman of the Supervisory Board of Zalando SE.


Our locations


Overview of subsidiaries

In the overview you will find our subsidiaries with focus on our company brands and groups within the Dermapharm Group. If required, further locations of these company brands abroad can be shown if available. The detailed organization chart of the Group structures and interests can be found in ur Annual Report.


acis® Arzneimittel GmbH

acis® - a modern pharmaceutical company. Our mission is Our mission is health, our drugs are generics, our passion is quality. What the future brings, we determine through our actions in the present. The added value of our medicines is at the heart of everything we do. Our contribution ensures that the benefits of the generic drug idea are sustainable. The product range currently includes 40 active ingredients for the therapy of a wide variety of clinical pictures ranging from allergies to epilepsy.




At Allergopharma, we have 50 years of experience in researching and treating allergies. We are the specialist for subcutaneous immunotherapy (SCIT) and the market leader in this field in Germany. For SCIT, we offer a wide range of high-dose, hypoallergenic preparations, so-called allergoids. In addition, our portfolio includes a wide range of allergens for diagnostics.


Dermapharm is a fast-growing manufacturer of branded pharmaceuticals. Founded in 1991, the company is based in Grünwald near Munich. The company's integrated business model comprises in-house development and production as well as the distribution of branded products by a pharmaceutically trained sales force. In addition to the main site in Brehna near Leipzig, Dermapharm operates further production, development and sales sites within Europe, primarily in Germany, as well as in the USA.


Hasan Dermapharm Co. Ltd.

HASAN - DERMAPHARM JOINT VENTURE CO., LTD is located in Thuan An, Binh Duong, Vietnam and is part of the Pharmaceutical and Medicine Manufacturing Industry. HASAN - DERMAPHARM JOINT VENTURE CO., LTD has 300 total employees across all of its locations.




mibe GmbH Arzneimittel is a high-performance, medium-sized pharmaceutical manufacturer that has been developing and producing quality preparations in a state-of-the-art pharmaceutical plant in the Leipzig/Halle area since 2003. Almost all products marketed by the Dermapharm Group are produced there. This is a clear commitment to Germany as a business location.


Strathmann GmbH & Co. KG

We are a medium-sized company with a Hanseatic attitude, a family spirit and a successful history. The founder and name giver was Dr. med. Detlef Strathmann. Since the very beginning we have been Hamburgers, cosmopolitan and at the same time connected to Germany as a business location: Our medicines are produced in Germany with high quality and short delivery routes, and the active ingredients come predominantly from Europe. Since 2018, we have been part of the Dermapharm AG group of companies.



SUN-FARM Sp. U. o. O

The company produces and distributes pharmaceuticals, medical devices and food supplements for humans and animals. The main areas of activity are steroids, dermatics and painkillers. It was founded in 1991. Currently, it employs about 90 people. The main products are: Dekristol, Psotriol, Myditin, Drotafemme, Momecutan. Sun Farm has its own wholesalers with direct sales to pharmacies and also produces food supplements for humans and small animals.



Trommsdorff GmbH & Co. KG

Trommsdorff is a modern medium-sized company for the production, galenic development and distribution of medicinal products, food supplements and complementary balanced diets. In addition, Trommsdorff also sells medical products. Challenges have always been the driving force for new developments at Trommsdorff. The affiliation to the Dermapharm Group strengthens the company for the requirements of the globalised markets. Today Trommsdorff operates with a broader, international perspective and uses the synergy effects within the Dermapharm network. This also inspires Trommsdorff's innovative strength, increases growth and efficiency - to the benefit of the customers.



CORAT Therapeutics GmbH

CORAT Therapeutics GmbH is a clinical phase biopharmaceutical company dedicated to develop therapeutic products to fight SARS-CoV-2 mediated COVID-19. CORAT was founded as a spin off from the recombinant antibody development company Yumab GmbH. It´s most advanced clinical product, the antibody COR-101, was discovered in the lab of Prof. Dr. Stefan Dübel and Prof. Dr. Michael Hust at the Braunschweig University of Technology.



Montavit GmbH

The pharmaceutical factory Montavit GmbH in Absam, Austria, offers solutions in the therapeutic areas of respiratory tract, relaxation & sleep, women's health, urinary tract, skin & allergy, travel pharmacy and digestive system. On 7 June 2023, Dermapharm acquired a significant stake in Montavit.


Euromed Gruppe

Founded in 1971 by German pharmaceutical group Madaus, Euromed is a GMP-certifed, leading manufacturer of premium-quality, gold-standard botanical extracts to support health and well-being. In 2019, Euromed was acquired by the renowned German pharmaceutical group Dermapharm.


Candoro ethics

As the market leader for dronabinol in Germany, the Candoro ethics develops, produces and markets natural and synthetic cannabinoids and also occupies a leading market position in Austria. The main therapeutic areas of dronabinol are pain and palliative medicine as well as oncology and neurology, covering a broad spectrum of chronic and severe diseases.


AB Cernelle

AB Cernelle is a pharmaceuticals company that has been producing herbal pharmaceuticals from high-quality pollen extracts since 1953. By deploying state-of-the art technology and qualitative research and development, the company has developed the API Cernitin™ from pollen extract, which is processed in the form of tableting powder and ready tableting blends. This phytopharmaceutical is used to treat urinary tract diseases such as benign prostate hyperplasia and chronic prostatitis.




MibeTec US, Inc. is part of mibeTec GmbH, Germany. mibeTec GmbH is a high-quality medical device manufacturer that is actively developing and manufacturing superior products in state-of-the-art medical device laboratories and factories in Germany. The products of mibeTec have been marketed for over 20 years in Germany and today are available in 25 countries worldwide.



The Uniqe™ system includes everything you need for easy and reliable dental care.



Anton Hübner GmbH & Co. KG

HÜBNER products are manufactured both according to traditional recipes with their tried and tested active ingredients and according to the latest scientific findings. Today, highly motivated employees ensure the continuity of the company as well as the product and quality philosophy. According to the motto "Tradition and innovation meet in Ehrenkirchen", new developments are pursued in addition to the improvement of existing products. HÜBNER products combine a high degree of quality, effectiveness and compatibility according to nature's recipe and are suitable for the whole family.



Hübner Naturarzneimittel GmbH

HÜBNER Naturarzneimittel GmbH is a company of the Dermapharm Group based in Ehrenkirchen and operated under the name MEDOPHARM Arzneimittel GmbH & Co. KG. It is a medium-sized company that was founded in Munich in 1932 and has stood for natural preparations from pharmacies for many decades. HÜBNER Naturarzneimittel GmbH is the market leader in the field of silica products in pharmacies and offers an innovative range of natural-based products. With pharmaceutical precision, not only medicinal products and medical devices, but also food supplements and cosmetics are developed and produced in Germany.




Arkopharma is a pharmaceutical laboratory specialising in the field of phytotherapy, natural medicines and dietary supplements. The products cover the therapeutic areas of blood circulation, colds - throat and pharynx, joints, hair & nails, urinary tract comfort, skin, immune system - defences, fatigue & energy and sleep & stress, among others. Arkopharma has been part of the Dermapharm Group since 05 January 2023.

Tiroler Nussöl Sonnenkosmetik GmbH (AT)

Tiroler Nussöl is not just any sun cosmetic - but rather the epitome of it. Nowhere are tradition, passion and joie de vivre so close together as in the brand with the Tyrolean eagle. For over 100 years, the oil with the extract of the green walnut shell has stood for sun protection with natural light protection. It once became the most popular sun oil in Austria and Germany. Tyrolean walnut oil gives a long-lasting, deep tan. And surrounds a person with that certain something. Whether in Kitzbühel, St. Moritz or on the Côte d'Azur - or in the garden at home.



Wellster Healthtech

Wellster Healthtech solves everyday medical undersupplies by giving people new access to effective treatment options.



MELASAN Produktions- und Vertriebsges.m.b.H.

For 25 years, we have been developing and producing a wide range of diverse products and services with and for our clients. Thanks to our long-standing strategic partnerships with pharmacies, we are considered the hidden champion of private label manufacturers in the Austrian OTC market. In addition to large market suppliers, many small companies, start-ups or (online) shop operators in the DACH region are among our customers.



axicorp Group

We are one of the leading experts in the parallel import and re-import of EU medicines and an expanding manufacturer of German-made over-the-counter medicines. In this context, the trust factor is particularly important throughout the entire value chain: both between patient and pharmacist and between pharmacist, business partners and us. Together, we pursue a course that is geared towards safe and good healthcare in order to support a functioning healthcare system.